• Profile
Close

Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract

BMC Ophthalmology Jun 10, 2021

Ren Y, Du S, Zheng D, et al. - Researchers conducted this retrospective cohort study to assess the effectiveness and safety of phacoemulsification with intravitreal 3 mg triamcinolone acetonide injection in preventing postoperative inflammation and complications in patients with non-infectious anterior uveitis and panuveitis complicated cataract. From January 2018 to January 2020, 140 uveitic cataract patients who received phacoemulsification and intraocular lens implantation in Shanxi Eye hospital were reviewed. Intraoperative intravitreal injection of 3 mg triamcinolone acetonide is an effective and safe adjunctive therapy for preventing postoperative inflammation and complications and promoting early recovery in patients with anterior uveitis or panuveitis complicated cataracts after phacoemulsification.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay